Advertisement
Home »

Advanced glycation end products are associated with cardiovascular risk in the Mexican population.

Feb 27, 2023

ABOUT THE CONTRIBUTORS

  • Karina Robles-Rivera

    Research Center in Policy, Population, and Health, School of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico. Electronic address: krobles@facmed.unam.mx.

    Berenice Rivera-Paredez

    Research Center in Policy, Population, and Health, School of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico. Electronic address: bereriverap@comunidad.unam.mx.

    Amado D Quezada-Sanchéz

    Center for Evaluation and Surveys Research, National Institute of Public Health, Cuernavaca 62100, Mexico. Electronic address: amado.quezada@insp.mx.

    Rafael Velázquez-Cruz

    Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City 14610, Mexico. Electronic address: rvelazquez@inmegen.gob.mx.

    Jorge Salmerón

    Research Center in Policy, Population, and Health, School of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico. Electronic address: drjorgesalmeron@unam.mx.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement